ALFA Finder| Revenue growth | FY26 revenue grew 15.4% YoY to ₹1,081 Cr. |
|---|---|
| Margins | FY26 EBITDA margin at 20.2%; Q4 FY26 improved to 21.3%. |
| Demand visibility | Strong demand in cardiology, oncology, and organ transplants; high international demand. |
| Management confidence | Confident in navigating regulatory challenges through operational agility and cost management. |
Growth
FY26 Revenue grew 15.4% to ₹1,081 Cr; PAT rose 26.2% to ₹104 Cr. Q4 FY26 EBITDA margin reached 21.3%.
Outlook
Targeting 2,000 beds by 2029. FY27 capex planned at ₹100 Cr. Raipur hospital commissioning in Q1 FY27.
Risks
Impact of West Asia war on international patient traffic and potential government-imposed margin caps on medical devices.
Earnings Call filed with NSE, NSE: ARTEMISMED. Summary written with AI assistance from the document.
Artemis Medicare Services Ltd: key numbers
- Share price
- ₹313.50
- Market cap
- ₹4,963 Cr
- Revenue (annual)
- ₹1,081 Cr
- Net profit (annual)
- ₹103.6 Cr
- P/E (TTM)
- 43.3×Sector 54.5×
- Promoter holding
- 58.39%+0.00% QoQ
- FII holding
- 12.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Artemis Medicare Services Ltd
All →Artemis Medicare Services Earnings Call Transcript: Key Takeaways
Artemis reports strong growth led by Gurgaon's record EBITDA and new Raipur operations. Aggressive expansion plans aim for 2,000 beds within five years despite regulatory drug pricing concerns.
Artemis Medicare Services Other Announcement
Artemis Medicare filed CARE Ratings' quarterly monitoring report on its Rs.330 crore preferential issue. It reports no deviation, with proceeds used as per the disclosed objects.
Artemis Medicare Services Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue INR 31,104 Lacs (+13.2% YoY); adj. EBITDA INR 7,150 Lacs (+22.7%, 23.3% margin); PAT INR 3,110 Lacs (+3.7%). Raipur ramp-up dilutes reported margins.
Artemis Medicare Services Results Update
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Artemis Medicare Services Q2 FY27 Results: Net Profit ₹31.1 Cr, Up 3.7% YoY
Artemis Medicare Services Ltd reported revenue from operations of ₹311 Cr (+13.2% YoY) and net profit of ₹31.1 Cr (+3.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹31.1 Cr · +3.7% YoY
Artemis Medicare Services Board Meeting Date
Artemis Medicare scheduled a board meeting for Oct 30, 2026 to approve Q1 un-audited results. Trading window remains closed until Nov 1, 2026.